CHACO Study: Control of Arterial Hypertension in Colombian Patients

Study Overview
=================
Brief Summary
-----------------
Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

Detailed Description
-----------------
OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment. MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in mono-tablet versus multi-tablet. The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.

Official Title
-----------------
CHACO Study: Control of Arterial Hypertension in Colombian Patients

Conditions
-----------------
Hypertension

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age ≥ 18 years Prior diagnosis of Arterial Hypertension (AH) ≥ 3 months before Patients who are under pharmacological treatment of AH ≥ 3 months before Exclusion Criteria: The patient has rejected the participation in the study. Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer the questions. Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patients with adequate control of the Blood Pressure (BP) | Proportion of patients who present an adequate control of the Blood Pressure (BP) | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Demographic analysis | Characterization of patients | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | 
| Treatment analysis | Characterization of treatment (s) used | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | 
| Personal history of diseases | Evaluation of personal history of diseases | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. | 
| Adverse Events related with the treatment | Adverse events associated with the treatment (s) | It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years. |